{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:20:00Z","timestamp":1788448800239,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR070549"],"award-info":[{"award-number":["AR070549"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["R01AI154932"],"award-info":[{"award-number":["R01AI154932"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ajt.2023.02.022","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T02:01:03Z","timestamp":1677895263000},"page":"759-775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-0603","authenticated-orcid":false,"given":"Amy P.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1070-9315","authenticated-orcid":false,"given":"Simon","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyd M.","family":"Castro-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7754-8355","authenticated-orcid":false,"given":"Ashley A.","family":"Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5864-5093","authenticated-orcid":false,"given":"Krishna M.","family":"Roskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna M.","family":"Gehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1298-4150","authenticated-orcid":false,"given":"Adele","family":"Rike-Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4835-9197","authenticated-orcid":false,"given":"Rita R.","family":"Alloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Allman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0421-8483","authenticated-orcid":false,"given":"David A.","family":"Hildeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-0842","authenticated-orcid":false,"given":"E. Steve","family":"Woodle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajt.2023.02.022_bib1","series-title":"Annual Data Report","year":"2022"},{"issue":"5","key":"10.1016\/j.ajt.2023.02.022_bib2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ctr.12722","article-title":"Re-transplants compared to primary kidney transplants recipients: a mate kidney paired analysis of the OPTN\/UNOS database","volume":"30","author":"Khalil","year":"2016","journal-title":"Clin Transpl"},{"issue":"8","key":"10.1016\/j.ajt.2023.02.022_bib3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2215\/CJN.01530219","article-title":"Access to kidney transplantation after a failed first kidney transplant and associations with patient and allograft survival","volume":"14","author":"Clark","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.ajt.2023.02.022_bib4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J\u00a0\u200bAm Soc Nephrol"},{"issue":"11","key":"10.1016\/j.ajt.2023.02.022_bib5","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/TP.0000000000000741","article-title":"A\u00a0\u200bPhase I\/II trial of the interleukin-6 receptor-specific humanized monoclonal (tocilizumab) + intravenous immunoglobulin in difficult to desensitize patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ajt.2023.02.022_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.08140910","article-title":"Desensitization protocols and their outcome","volume":"6","author":"Marfo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ajt.2023.02.022_bib7","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 Trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J\u00a0\u200bAm Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ajt.2023.02.022_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/ajt.15634","article-title":"Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells","volume":"20","author":"Woodle","year":"2020","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2023.02.022_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/ajt.15613","article-title":"A\u00a0\u200bprospective, iterative, adaptive trial of carfilzomib-based desensitization","volume":"20","author":"Tremblay","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2023.02.022_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/ajt.13050","article-title":"Prospective iterative trial of proteasome inhibitor-based desensitization","volume":"15","author":"Woodle","year":"2015","journal-title":"Am J Transplant"},{"issue":"17","key":"10.1016\/j.ajt.2023.02.022_bib11","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1089\/ars.2014.5892","article-title":"Review of bortezomib treatment of antibody-mediated rejection in renal transplantation","volume":"21","author":"Ejaz","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"10.1016\/j.ajt.2023.02.022_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/TP.0b013e318257acf6","article-title":"Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients","volume":"94","author":"Schmidt","year":"2012","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.ajt.2023.02.022_bib13","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ki.2011.502","article-title":"Proteasome inhibitor-based therapy for antibody-mediated rejection","volume":"81","author":"Walsh","year":"2012","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ajt.2023.02.022_bib14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-6143.2009.02577.x","article-title":"Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss","volume":"9","author":"Everly","year":"2009","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.ajt.2023.02.022_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.transproceed.2008.10.073","article-title":"Proteasome inhibition reduces donor-specific antibody levels","volume":"41","author":"Everly","year":"2009","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.ajt.2023.02.022_bib16","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2023.02.022_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.seminhematol.2012.04.005","article-title":"The proteasome in terminal plasma cell differentiation","volume":"49","author":"Cenci","year":"2012","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.ajt.2023.02.022_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ceb.2010.11.004","article-title":"Proteostenosis and plasma cell pathophysiology","volume":"23","author":"Cenci","year":"2011","journal-title":"Curr Opin Cell Biol"},{"issue":"5","key":"10.1016\/j.ajt.2023.02.022_bib19","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.emboj.7601009","article-title":"Progressively impaired proteasomal capacity during terminal plasma cell differentiation","volume":"25","author":"Cenci","year":"2006","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.ajt.2023.02.022_bib20","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2016070727","article-title":"Humoral compensation after bortezomib treatment of allosensitized recipients","volume":"28","author":"Kwun","year":"2017","journal-title":"J\u00a0\u200bAm Soc Nephrol"},{"issue":"10","key":"10.1016\/j.ajt.2023.02.022_bib21","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1111\/ajt.16061","article-title":"Pharmacological approaches to antibody-mediated rejection\u2014are we getting closer?","volume":"20","author":"Kwun","year":"2020","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.ajt.2023.02.022_bib22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4049\/jimmunol.169.3.1277","article-title":"Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response","volume":"169","author":"Hauser","year":"2002","journal-title":"J\u00a0\u200bImmunol"},{"issue":"4","key":"10.1016\/j.ajt.2023.02.022_bib23","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4049\/jimmunol.171.4.1684","article-title":"Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals","volume":"171","author":"Cassese","year":"2003","journal-title":"J\u00a0\u200bImmunol"},{"issue":"8","key":"10.1016\/j.ajt.2023.02.022_bib24","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/eji.201344313","article-title":"Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cells","volume":"44","author":"Zehentmeier","year":"2014","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.ajt.2023.02.022_bib25","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.170.3.1136","article-title":"Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues","volume":"170","author":"Nakayama","year":"2003","journal-title":"J\u00a0\u200bImmunol"},{"issue":"6","key":"10.1016\/j.ajt.2023.02.022_bib26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.175.6.1739","article-title":"VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion","volume":"175","author":"Rold\u00e1n","year":"1992","journal-title":"J\u00a0\u200bExp Med"},{"issue":"6","key":"10.1016\/j.ajt.2023.02.022_bib27","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.4049\/jimmunol.167.6.3064","article-title":"Diverse transcriptional response of CD4+T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4+T cells","volume":"167","author":"Suzuki","year":"2001","journal-title":"J\u00a0\u200bImmunol"},{"issue":"1-2","key":"10.1016\/j.ajt.2023.02.022_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.imlet.2008.07.006","article-title":"CXCL12\/CXCR4 signaling promotes human thymic dendritic cell survival regulating the Bcl-2\/Bax ratio","volume":"120","author":"Hern\u00e1ndez-L\u00f3pez","year":"2008","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ajt.2023.02.022_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/2040206619829382","article-title":"Mozobil\u00ae (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration","volume":"27","author":"De Clercq","year":"2019","journal-title":"Antivir Chem Chemother"},{"issue":"3","key":"10.1016\/j.ajt.2023.02.022_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.humimm.2016.12.009","article-title":"Calculated panel reactive antibody with decimals: a refined metric of access to transplantation for highly sensitized candidates","volume":"78","author":"Kransdorf","year":"2017","journal-title":"Hum Immunol"},{"issue":"11","key":"10.1016\/j.ajt.2023.02.022_bib31","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1517\/14712598.8.11.1797","article-title":"Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells","volume":"8","author":"Uy","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"10.1016\/j.ajt.2023.02.022_bib32","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1172\/JCI17244","article-title":"CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells","volume":"111","author":"Kunkel","year":"2003","journal-title":"J\u00a0\u200bClin Invest"},{"issue":"Pt 26","key":"10.1016\/j.ajt.2023.02.022_bib33","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1242\/jcs.01575","article-title":"Sem1, the yeast ortholog of a human BRCA2-binding protein, is a component of the proteasome regulatory particle that enhances proteasome stability","volume":"117","author":"Funakoshi","year":"2004","journal-title":"J\u00a0\u200bCell Sci"},{"key":"10.1016\/j.ajt.2023.02.022_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fmolb.2019.00116","article-title":"The role of iron regulation in immunometabolism and immune-related disease","volume":"6","author":"Cronin","year":"2019","journal-title":"Front Mol Biosci"},{"issue":"6","key":"10.1016\/j.ajt.2023.02.022_bib35","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cell.2020.02.017","article-title":"A\u00a0\u200bgenome-wide ER-phagy screen highlights key roles of mitochondrial metabolism and ER-resident UFMylation","volume":"180","author":"Liang","year":"2020","journal-title":"Cell"},{"issue":"1-2","key":"10.1016\/j.ajt.2023.02.022_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","article-title":"Biological functions of autophagy genes: a disease perspective","volume":"176","author":"Levine","year":"2019","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ajt.2023.02.022_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/ni.2524","article-title":"Plasma cells require autophagy for sustainable immunoglobulin production","volume":"14","author":"Pengo","year":"2013","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.ajt.2023.02.022_bib38","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4161\/auto.24399","article-title":"The role of autophagy in plasma cell ontogenesis","volume":"9","author":"Pengo","year":"2013","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.ajt.2023.02.022_bib39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/15548627.2015.1052928","article-title":"A\u00a0\u200bplastic SQSTM1\/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells","volume":"11","author":"Milan","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.ajt.2023.02.022_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59850","article-title":"Genetic timestamping of plasma cells in vivo reveals tissue-specific homeostatic population turnover","volume":"9","author":"Xu","year":"2020","journal-title":"Elife"},{"issue":"37","key":"10.1016\/j.ajt.2023.02.022_bib41","doi-asserted-by":"crossref","first-page":"14767","DOI":"10.1523\/JNEUROSCI.2954-12.2013","article-title":"Deficiency of p62\/Sequestosome 1 causes hyperphagia due to leptin resistance in the brain","volume":"33","author":"Harada","year":"2013","journal-title":"J\u00a0\u200bNeurosci"},{"issue":"21","key":"10.1016\/j.ajt.2023.02.022_bib42","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1073\/pnas.1118193109","article-title":"Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency","volume":"109","author":"McAfee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.ajt.2023.02.022_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224137","article-title":"Statistical determination of synergy based on Bliss definition of drugs independence","volume":"14","author":"Demidenko","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ajt.2023.02.022_bib44","series-title":"MOZOBIL\u00ae(plerixafor) Product Monograph","year":"2019"},{"issue":"9","key":"10.1016\/j.ajt.2023.02.022_bib45","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1182\/blood.V76.9.1739.1739","article-title":"Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry","volume":"76","author":"Terstappen","year":"1990","journal-title":"Blood"},{"issue":"50","key":"10.1016\/j.ajt.2023.02.022_bib46","doi-asserted-by":"crossref","first-page":"20012","DOI":"10.1073\/pnas.1116110108","article-title":"Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age","volume":"108","author":"Pang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ajt.2023.02.022_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011316","article-title":"Selective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model","volume":"5","author":"Kang","year":"2010","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.ajt.2023.02.022_bib48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cell.2017.11.003","article-title":"Rapid mobilization reveals a highly engraftable hematopoietic stem cell","volume":"172","author":"Hoggatt","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ajt.2023.02.022_bib49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4049\/jimmunol.1700461","article-title":"Here, there, and anywhere? Arguments for and against the physical plasma cell survival niche","volume":"199","author":"Wilmore","year":"2017","journal-title":"J\u00a0\u200bImmunol"},{"key":"10.1016\/j.ajt.2023.02.022_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.791095","article-title":"IgA plasma cells are long-lived residents of gut and bone marrow that express isotype- and tissue-specific gene expression patterns","volume":"12","author":"Wilmore","year":"2021","journal-title":"Front Immunol"},{"issue":"19","key":"10.1016\/j.ajt.2023.02.022_bib51","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood-2016-09-739722","article-title":"Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft","volume":"129","author":"Schroeder","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ajt.2023.02.022_bib52","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3389\/fimmu.2015.00429","article-title":"Diversity and inter-connections in the CXCR4 chemokine receptor\/ligand family: molecular perspectives","volume":"6","author":"Pawig","year":"2015","journal-title":"Front Immunol"},{"issue":"suppl 2","key":"10.1016\/j.ajt.2023.02.022_bib53","article-title":"CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease","volume":"48","author":"De Filippo","year":"2018","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.ajt.2023.02.022_bib54","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/ajt.14236","article-title":"Impact of CXCR4\/CXCL12 blockade on normal plasma cells in vivo","volume":"17","author":"Moore","year":"2017","journal-title":"Am J Transpl"},{"issue":"1","key":"10.1016\/j.ajt.2023.02.022_bib55","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1038\/s41467-018-05853-7","article-title":"Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion","volume":"9","author":"Nguyen","year":"2018","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ajt.2023.02.022_bib56","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1080\/15548627.2017.1356549","article-title":"SQSTM1\/p62-mediated autophagy compensates for loss of proteasome polyubiquitin recruiting capacity","volume":"13","author":"Demishtein","year":"2017","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.ajt.2023.02.022_bib57","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1083\/jcb.201708168","article-title":"Rapid induction of p62 and GABARAPL1 upon proteasome inhibition promotes survival before autophagy activation","volume":"217","author":"Sha","year":"2018","journal-title":"J\u00a0\u200bCell Biol"},{"issue":"8","key":"10.1016\/j.ajt.2023.02.022_bib58","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.4161\/auto.29264","article-title":"Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed\/refractory myeloma","volume":"10","author":"Vogl","year":"2014","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.ajt.2023.02.022_bib59","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/eji.201747023","article-title":"CXCR4\u2013CXCL12 interaction is\u00a0important for plasma cell homing and survival in NZB\/W mice","volume":"48","author":"Cheng","year":"2018","journal-title":"Eur J\u00a0Immunol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523003076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613523003076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:39:44Z","timestamp":1761629984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613523003076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1600613523003076"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2023.02.022","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2023.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}